Difluorodeoxycytidine (dFdC)--gemcitabine: a phase I study.

Difluorodeoxycytidine (dFdC)--gemcitabine: a phase I study.

Item
http://www.wikidata.org/entity/Q33355905
Toxicity of a 24-hour infusion of gemcitabine in biliary tract and pancreatic cancer: a pilot study.Gemcitabine twice weekly as a radiosensitiser for the treatment of brain metastases in patients with carcinoma: a phase I studyA 21-day schedule of gemcitabine and cisplatin administration in the treatment of advanced non-small cell lung carcinoma: a phase II studyNeoadjuvant gemcitabine-based accelerated hyperfractionation chemoradiotherapy for patients with borderline resectable pancreatic adenocarcinoma.Phase I trial of radiotherapy concurrent with twice-weekly gemcitabine for head and neck cancer: translation from preclinical investigations aiming to improve the therapeutic ratio.On the development of gemcitabine-based chemoradiotherapy regimens in pancreatic cancer.Mistletoe and gemcitabine in patients with advanced cancer: a model for the phase I study of botanicals and botanical-drug interactions in cancer therapy.A phase I study of a combination of yttrium-90-labeled anti-carcinoembryonic antigen (CEA) antibody and gemcitabine in patients with CEA-producing advanced malignanciesA phase I study of a 24 hour infusion of gemcitabine in previously untreated patients with inoperable non-small-cell lung cancer.Phase I study of gemcitabine using a once every 2 weeks schedule.Prolonged fixed dose rate infusion of gemcitabine with autologous haemopoietic support in advanced pancreatic adenocarcinoma.D- and L-2',3'-didehydro-2',3'-dideoxy-3'-fluoro-carbocyclic nucleosides: synthesis, anti-HIV activity and mechanism of resistanceInterleukin 6 is a cause of flu-like symptoms in treatment with a deoxycytidine analogue.Intraoperative and early postoperative chemotherapy into the abdominal cavity using gemcitabine may prevent postoperative occurence of peritoneal carcinomatosis.
P2860

Difluorodeoxycytidine (dFdC)--gemcitabine: a phase I study.

Item
http://www.wikidata.org/entity/Q33355905
description
1992 nî lūn-bûn
@nan
1992 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年学术文章
@wuu
1992年学术文章
@zh-cn
1992年学术文章
@zh-hans
1992年学术文章
@zh-my
1992年学术文章
@zh-sg
1992年學術文章
@yue
name
Difluorodeoxycytidine (dFdC)--gemcitabine: a phase I study.
@ast
Difluorodeoxycytidine (dFdC)--gemcitabine: a phase I study.
@en
type
label
Difluorodeoxycytidine (dFdC)--gemcitabine: a phase I study.
@ast
Difluorodeoxycytidine (dFdC)--gemcitabine: a phase I study.
@en
prefLabel
Difluorodeoxycytidine (dFdC)--gemcitabine: a phase I study.
@ast
Difluorodeoxycytidine (dFdC)--gemcitabine: a phase I study.
@en
P1433
P1476
P2093
P2888
P304
P31
P356
P433
P478
P577
P6179
P698
P356
P1433
P1476
Difluorodeoxycytidine (dFdC)--gemcitabine: a phase I study.
@en
P2093
P2888
P304
P31
P356
P433
P478
P577
P6179
P698